AGN - Evolus: A Wrinkle For Botox
Newport Beach, California-based Evolus (NASDAQ:EOLS) is the newest entrant in the injectable aesthetics market. The business is strategized around a single product, a botulinum toxin marketed as Jeuveau. Their strategy focuses solely on the self-pay portion of the market, which we see as a logical development within the medical aesthetics space.
Haute Culture
By far the dominant player in the aesthetic injectables market is Botox (Allergan (NYSE:AGN)). It is a purified form of botulinum toxin A (BTX-A), a neurotoxic protein used to produce temporary muscular paralysis, derived from bacterial cultures. When